Physician profile
Drew Lansdown
NPI 1356669899
$28,995.17
in general payments reported to CMS, 2019-2025
9 companies · $630 in 2025
The $630 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,343 · 2020: $127 · 2021: $4,500 · 2022: $2,879 · 2023: $3,232 · 2024: $16K · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Consulting Fee: $8,263 · Food and Beverage: $1,866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,017.17 |
| Consulting Fee | $8,262.50 |
| Food and Beverage | $1,865.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $16,541.95 | 2019-2025 | Allograft Tissue, Livatec Knee Preservation System, Biobrace 23mm |
| Vericel Corporation | $7,787.69 | 2021-2025 | Maci |
| Evolution Surgical, INC | $2,327.07 | 2019-2025 | |
| Stryker Corporation | $1,960.66 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed, Aequalis Flex Revive |
| Aesculap Biologics, LLC | $127.00 | 2020 | |
| Arthrex, INC. | $97.86 | 2025 | |
| Abanza INC. | $89.87 | 2025 | Washercap Mini Fixation System 4.5mm, Washercap Fixation System 10mm |
| Zimmer Biomet Holdings, INC. | $38.27 | 2022 | |
| Depuy Synthes Sales INC. | $24.80 | 2023 | Rigidloop, Speedtrap, Vapr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drew Lansdown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.